website QUALITY MEDICAL & DENTAL PRODUCTS

Septocaine Articaine HCl 4% with Epinephrine 1:200,000 Cartridges Box of 50 - 1.7 mL

Description

Septocaine Articaine HCl 4% with Epinephrine 1:200,000 Cartridges Box of 50 - 1.7 mL

Product Details

Description:
Septocaine - Articaine HCl 4% with Epinephrine 1:200,000. Box of 50 - 1.7 mL Cartridges. Suitable for most routine dental procedures. No-methylparaben formulation and latex free components help avoid allergic reactions on sensitive patients. Packages in 5 blister packs with 10 x 1.7ml glass cartridges each. **Anesthetics are non-returnable.
Manufacturer Code:
01A1200
Brand:
Septocaine
Packaging:
Package of 50 - 1.7 ml cartridges
Type:
Articaine 4%
Vasoconstrictor:
Epinephrine 1:200,000

Articaine HCl. 4% and Epinephrine 1:200,000 Injection

Indications

  • Local dental anesthesia in both simple and complex dental procedures.

Features & benefits

  • Septocaine® is the # 1 Branded Dental Anesthetic in the United States*.
  • For most routine dental procedures Septocaine and epinephrine 1:200,000 is preferred.
  • Fast onset (1 to 9 minutes ) to avoid delay before effective analgesia is achieved.
  • Predictable duration of anesthesia : up to 60 minutes for infiltration injections and 120 minutes for nerve blocks.
  • No-methylparaben formulation to avoid allergic reactions on sensitive patients.
  • 100 percent latex free components to help reduce allergic responses.
  • Terminal sterilization of product/cartridges for safe use.
  • Mylar label covered glass cartridges to minimize risk of wound in the event of a cartridge breakage.
  • Cartridges packed 10 to a blister tray to avoid glass to glass contact, hence reducing breakage.
  • * Source: SDM data

Presentation

  • Item #01A1200 – Box containing 5 blisters of 10 x 1.7ml glass cartridges

Risk information

  • Septocaine® is indicated for local, infiltrative, or conductive anesthesia in both simple and complex dental procedures. Septocaine® and epinephrine 1:100,000 is preferred during operative or surgical procedures when improved visualization of the surgical field is desirable. Reactions to Septocaine® (pain and headache, for example, or convulsions or respiratory arrest following accidental intravascular injection) are characteristic of those associated with other amide-type local anesthetics. Septocaine® contains sodium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. Accidental intravascular injection may be associated with convulsions, followed by central nervous system or cardiorespiratory depression and coma, progressing ultimately to respiratory arrest. Dental practitioners and/or clinicians who employ local anesthetic agents should be well versed in diagnosis and management of emergencies that may arise from their use. Resuscitative equipment, oxygen, and other resuscitative drugs should be available for immediate use. Septocaine®, along with other local anesthetics, is capable of producing methemoglobinemia. The clinical signs of methemoglobinemia are cyanosis of the nail beds and lips, fatigue and weakness. If methemoglobinemia does not respond to administration of oxygen, administration of methylene blue intravenously 1-2 mg/kg body weight over a 5 minute period is recommended. Please see the Package Insert for prescribing information.

 

The sale of this item may be subject to regulation by the U.S. Food and Drug Administration and state and local regulatory agencies. If the item is subject to FDA regulation, We will verify your status as an authorized purchaser of this item before shipping of the item.

Product form

Septocaine Articaine HCl 4% with Epinephrine 1:200,000 Cartridges Box of 50 - 1.7 mL Product Details Description: Septocaine - Articaine... Read more

SKU: 01A1200
Barcode: 51273904

Login to see prices Login to see prices Excl. VAT

  • Shipped today? Order within: Mar 24, 2023 17:00:00 -0400
Shipping information

Order processing time:

1-2 business days for order to process and shipped.

Delivery carriers:

UPS, FedEx and USPS. Tracking details will be provided to the customer via email.

Returns:


SurgiMac brand Products returns - If you are unsatisfied with your SurgiMac order, we offer a no risk return policy. Within 30 days of receipt, you may return your new and unused product in its resalable condition for a full refund minus the cost of the shipping label. A restocking fee may apply. For customized items, a refund may be issued if there was an error on our end. Unfortunately, all sales of infection control products are final and not eligible for a refund. Other brands - Brands other than SurgiMac, we will provide credit after we receive credit from the manufacturer. Our representative will serve as your advocate to resolve any issues quickly and fairly. If the manufacturer agrees that the product needs to be returned or replaced, we will provide the necessary installation services at no extra cost. Any manufacturer’s restocking fee will be your responsibility. Instructions: Inspect your order as soon as it arrives. To arrange a return, have your order number ready and reach out to us via live chat or email (info@surgimac.com). We'll get back to you within one business day with the next steps for obtaining a return authorization.

Ask a question

Description

Septocaine Articaine HCl 4% with Epinephrine 1:200,000 Cartridges Box of 50 - 1.7 mL

Product Details

Description:
Septocaine - Articaine HCl 4% with Epinephrine 1:200,000. Box of 50 - 1.7 mL Cartridges. Suitable for most routine dental procedures. No-methylparaben formulation and latex free components help avoid allergic reactions on sensitive patients. Packages in 5 blister packs with 10 x 1.7ml glass cartridges each. **Anesthetics are non-returnable.
Manufacturer Code:
01A1200
Brand:
Septocaine
Packaging:
Package of 50 - 1.7 ml cartridges
Type:
Articaine 4%
Vasoconstrictor:
Epinephrine 1:200,000

Articaine HCl. 4% and Epinephrine 1:200,000 Injection

Indications

  • Local dental anesthesia in both simple and complex dental procedures.

Features & benefits

  • Septocaine® is the # 1 Branded Dental Anesthetic in the United States*.
  • For most routine dental procedures Septocaine and epinephrine 1:200,000 is preferred.
  • Fast onset (1 to 9 minutes ) to avoid delay before effective analgesia is achieved.
  • Predictable duration of anesthesia : up to 60 minutes for infiltration injections and 120 minutes for nerve blocks.
  • No-methylparaben formulation to avoid allergic reactions on sensitive patients.
  • 100 percent latex free components to help reduce allergic responses.
  • Terminal sterilization of product/cartridges for safe use.
  • Mylar label covered glass cartridges to minimize risk of wound in the event of a cartridge breakage.
  • Cartridges packed 10 to a blister tray to avoid glass to glass contact, hence reducing breakage.
  • * Source: SDM data

Presentation

  • Item #01A1200 – Box containing 5 blisters of 10 x 1.7ml glass cartridges

Risk information

  • Septocaine® is indicated for local, infiltrative, or conductive anesthesia in both simple and complex dental procedures. Septocaine® and epinephrine 1:100,000 is preferred during operative or surgical procedures when improved visualization of the surgical field is desirable. Reactions to Septocaine® (pain and headache, for example, or convulsions or respiratory arrest following accidental intravascular injection) are characteristic of those associated with other amide-type local anesthetics. Septocaine® contains sodium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. Accidental intravascular injection may be associated with convulsions, followed by central nervous system or cardiorespiratory depression and coma, progressing ultimately to respiratory arrest. Dental practitioners and/or clinicians who employ local anesthetic agents should be well versed in diagnosis and management of emergencies that may arise from their use. Resuscitative equipment, oxygen, and other resuscitative drugs should be available for immediate use. Septocaine®, along with other local anesthetics, is capable of producing methemoglobinemia. The clinical signs of methemoglobinemia are cyanosis of the nail beds and lips, fatigue and weakness. If methemoglobinemia does not respond to administration of oxygen, administration of methylene blue intravenously 1-2 mg/kg body weight over a 5 minute period is recommended. Please see the Package Insert for prescribing information.

 

The sale of this item may be subject to regulation by the U.S. Food and Drug Administration and state and local regulatory agencies. If the item is subject to FDA regulation, We will verify your status as an authorized purchaser of this item before shipping of the item.

Recently viewed products

Login

Forgot your password?

Don't have an account yet?
Create account